Hans-Christoph Kirch - JoVE Visualize

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Cells, Tissues, Organs|November 12, 2002

Apoptotic genes in cancer therapyBertram Opalka, Alexandra Dickopp, Hans-Christoph Kirch

Journal of Controlled Release : Official Journal of the Controlled Release Society|February 1, 2005

Monoclonal antibody-polyethyleneimine conjugates targeting Her-2/neu or CD90 allow cell type-specific nonviral gene deliveryClaudia Strehblow, Maj Schuster, Thomas Moritz, et al.

Oncogene|November 20, 2002

Tumor-specific activation of hTERT-derived promoters by tumor suppressive E1A-mutants involves recruitment of p300/CBP/HAT and suppression of HDAC-1 and defines a combined tumor targeting and suppression systemHans-Christoph Kirch, Sabine Ruschen, Dieter Brockmann, et al.

Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Cells, Tissues, Organs|November 12, 2002

Apoptotic genes in cancer therapyBertram Opalka, Alexandra Dickopp, Hans-Christoph Kirch

Journal of Controlled Release : Official Journal of the Controlled Release Society|February 1, 2005

Monoclonal antibody-polyethyleneimine conjugates targeting Her-2/neu or CD90 allow cell type-specific nonviral gene deliveryClaudia Strehblow, Maj Schuster, Thomas Moritz, et al.

Oncogene|November 20, 2002

Tumor-specific activation of hTERT-derived promoters by tumor suppressive E1A-mutants involves recruitment of p300/CBP/HAT and suppression of HDAC-1 and defines a combined tumor targeting and suppression systemHans-Christoph Kirch, Sabine Ruschen, Dieter Brockmann, et al.

Pageof 1